Health care professionals who prescribe MMF or MPA to women of childbearing potential (including pubertal girls and peri-menopausal women) should be aware of the increased risk of fetal harm from exposure to these drugs during pregnancy and ways to mitigate this risk. Full Text
Due to system changes within the Health Regulations and Licensing Administration, beginning April 07, 2008, all application checks should be made payable to the DC Treasurer. Full Text
Health Professional Licensing Administration Department of Health 717 14th Street, NW, Suite 600 Washington, DC 20005 (202) 724-4900
